Assertio Holdings Inc (USD)
ASRT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.90 | 1.05
52-Wk Range- | -
Last Close0.97
Mkt Cap (m)165.97
Dividend yield-
ISINUS04546C1062
Volume13,776,754.00
Exchange VenueNAS

Company Profile

Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.

Key Information
Price/Earning-
Price/Book2.19
Price/Sales0.68
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 11/02/2021
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.assertiotx.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)342.74455.90380.72311.77229.50-
Operating Income (m)-80.3024.51-28.9364.26-0.75-
Net Income (m)-75.74-88.72-102.5036.91-217.20-
Basic EPS-1.26-1.45-1.630.58-3.07-
Avg. Diluted Shares Outstanding (m)60.1261.3062.7064.2170.72-
Balance Sheet
USD201520162017201820192020
Current Assets (m)308.97306.20230.85208.11103.95-
Non Current Assets (m)1,054.46919.13807.77724.76423.22-
Total Assets (m)1,363.431,225.341,038.62932.87527.17-
Current Liabilities (m)219.63227.24310.58246.04184.55-
Total Liabilities (m)------
Total Equity (m)315.06250.79169.51220.3457.96-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)143.8965.5062.1772.5090.48-
Capital Expenditure (m)-26.72-2.86-0.67-5.51-1.48-
Figures are quoted in USD unless stated otherwise
-
No change
$
0.97
Last Price